The adenosine triphosphate (ATP) swab test market was valued at US$ 198.21 million in 2019 and is projected to reach US$ 369.71 million by 2027; it is expected to grow at a CAGR of 8.10% from 2019 to 2027. The growth of the market is mainly attributed to the rising prevalence of healthcare associated infections (HAIs) and increasing emphasis on food safety. However, limitations of ATP swab tests limit the market growth.
HAIs, also known as nosocomial infections, are acquired while receiving treatment or therapies in healthcare facilities. These infections are related to surgical procedures and medical instruments used during procedures. HAIs are responsible for morbidity and mortality of significant number of patients in the world. According to a study published by the Centers for Disease Control and Prevention (CDC) in 2019, 1 in 31 hospital patients is estimated to have some kind of HAI. In addition, according to estimates by The European Centre for Disease Prevention and Control in 2019, ~4.1 million patients across Europe suffer due to HAIs every year. Furthermore, according to study published in the Journal of Antimicrobial Resistance & Infection Control in 2019, the incidence rate of HAIs in China was 3.62 per 1,000 patient days. Out of this rate of incidence, respiratory tract infection accounted for 43.80% of infections while bloodstream and urinary tract infections accounted for 15.74% and 12.69% of infections, respectively. The hospital visits and patient pool is likely to increase in the coming years due to the mounting prevalence of chronic conditions and outbreaks of infectious diseases. HAIs also contribute to this increasing population of patients. For instance, the World Health Organization (WHO) estimates published in 2019, 421 million hospitalizations are conducted worldwide every year. Of these, 42.7 million patients suffer from adverse reactions or infections acquired at healthcare settings. Also, according to the same estimates, 50.0% of these adverse events are preventable in developed countries. Thus, such rising prevalence of HAIs is one of the prominent factors driving the demand for ATP swab tests.
The implementation of safety measures to prevent the spread of COVID-19 is driving the adoption of adenosine triphosphate (ATP) swabs. Moreover, the major shift in focus toward microbial safety amid the pandemic is offering lucrative opportunities for the growth of the market players.
Based on type, the adenosine triphosphate (ATP) swab test market is segmented into free ATP test and microbial ATP test. The free ATP test segment held a larger share of the market in 2019; however, the microbial ATP test segment is estimated to register a higher CAGR during the forecast period. The rising number focus on food safety and sterilization on microbial level is estimated to offer lucrative opportunity for the microbial ATP test segment growth.
The adenosine triphosphate (ATP) swab test market, by application, is segmented into pharmaceutical and biotechnology companies, food and beverage, hospitals and diagnostics laboratories, and academic and research institutions. The pharmaceutical and biotechnology companies segment held the largest share of the market in 2019, and it is estimated to register the highest CAGR during the forecast period.
The World Health Organization (WHO), Food and Drug Administration (FDA), National Health Service (NHS), and Centers for Disease Control and Prevention (CDC) are among the major primary and secondary sources referred to while preparing this report.
HAIs, also known as nosocomial infections, are acquired while receiving treatment or therapies in healthcare facilities. These infections are related to surgical procedures and medical instruments used during procedures. HAIs are responsible for morbidity and mortality of significant number of patients in the world. According to a study published by the Centers for Disease Control and Prevention (CDC) in 2019, 1 in 31 hospital patients is estimated to have some kind of HAI. In addition, according to estimates by The European Centre for Disease Prevention and Control in 2019, ~4.1 million patients across Europe suffer due to HAIs every year. Furthermore, according to study published in the Journal of Antimicrobial Resistance & Infection Control in 2019, the incidence rate of HAIs in China was 3.62 per 1,000 patient days. Out of this rate of incidence, respiratory tract infection accounted for 43.80% of infections while bloodstream and urinary tract infections accounted for 15.74% and 12.69% of infections, respectively. The hospital visits and patient pool is likely to increase in the coming years due to the mounting prevalence of chronic conditions and outbreaks of infectious diseases. HAIs also contribute to this increasing population of patients. For instance, the World Health Organization (WHO) estimates published in 2019, 421 million hospitalizations are conducted worldwide every year. Of these, 42.7 million patients suffer from adverse reactions or infections acquired at healthcare settings. Also, according to the same estimates, 50.0% of these adverse events are preventable in developed countries. Thus, such rising prevalence of HAIs is one of the prominent factors driving the demand for ATP swab tests.
The implementation of safety measures to prevent the spread of COVID-19 is driving the adoption of adenosine triphosphate (ATP) swabs. Moreover, the major shift in focus toward microbial safety amid the pandemic is offering lucrative opportunities for the growth of the market players.
Based on type, the adenosine triphosphate (ATP) swab test market is segmented into free ATP test and microbial ATP test. The free ATP test segment held a larger share of the market in 2019; however, the microbial ATP test segment is estimated to register a higher CAGR during the forecast period. The rising number focus on food safety and sterilization on microbial level is estimated to offer lucrative opportunity for the microbial ATP test segment growth.
The adenosine triphosphate (ATP) swab test market, by application, is segmented into pharmaceutical and biotechnology companies, food and beverage, hospitals and diagnostics laboratories, and academic and research institutions. The pharmaceutical and biotechnology companies segment held the largest share of the market in 2019, and it is estimated to register the highest CAGR during the forecast period.
The World Health Organization (WHO), Food and Drug Administration (FDA), National Health Service (NHS), and Centers for Disease Control and Prevention (CDC) are among the major primary and secondary sources referred to while preparing this report.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Adenosine Triphosphate (ATP) Swab Test Market - ByType
1.3.2 Global Adenosine Triphosphate (ATP) Swab Test Market - By Application
1.3.3 Global Adenosine Triphosphate (ATP) Swab Test Market - By Geography
2. Adenosine Triphosphate (ATP) Swab Test Market- Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Adenosine Triphosphate (ATP) Swab Test Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East & Africa- PEST Analysis
4.2.5 South & Central America - PEST Analysis
4.3 Expert Opinion
5. Adenosine Triphosphate (ATP) Swab Test Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Healthcare-Associated Infections (HAI)
5.1.2 Increasing Emphasis on Food Safety
5.2 Market Restraint
5.2.1 Limitations of ATP Swab Tests
5.3 Market Opportunity
5.3.1 Growing Spending on Patient Safety and Care
5.4 Future Trend
5.4.1 Development of Adenylate (A3) Concentration Based Modern Sterility Monitoring System
5.5 Impact Analysis
6. Adenosine Triphosphate (ATP) Swab Test Market - Global Analysis
6.1 Global Adenosine Triphosphate (ATP) Swab Test Market Revenue Forecast and Analysis
6.2 Global Adenosine Triphosphate (ATP) Swab Test Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Adenosine Triphosphate (ATP) Swab Test Market Analysis and Forecasts To 2027 -Type
7.1 Overview
7.2 Global Adenosine Triphosphate (ATP) Swab Test Market Share by Type2019 & 2027 (%)
7.3 Free ATP Test
7.3.1 Overview
7.3.2 Free ATP Test Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Microbial ATP Test
7.4.1 Overview
7.4.1.1 Microbial ATP Test: Adenosine Triphosphate (ATP) Swab Test Market- Revenue and Forecast to 2027 (US$ Million)
8. Adenosine Triphosphate (ATP) Swab Test Market Analysis and Forecasts To 2027 - Application
8.1 Overview
8.2 Global Adenosine Triphosphate (ATP) Swab Test Market Share by Application 2019 & 2027 (%)
8.3 Pharmaceutical and Biotechnology Company
8.3.1 Overview
8.3.1.1 Pharmaceutical and biopharmaceutical companies: Adenosine Triphosphate (ATP) Swab Test Market- Revenue and Forecast to 2027 (US$ Million)
8.3.2 Food and Beverage
8.3.2.1 Overview
8.3.2.2 Food and Beverage: Adenosine Triphosphate (ATP) Swab Test Market- Revenue and Forecast to 2027 (US$ Million)
8.3.3 Hospitals and Diagnostics Laboratories
8.3.3.1 Overview
8.3.3.2 Hospitals and Diagnostics Laboratories: Adenosine Triphosphate (ATP) Swab Test Market- Revenue and Forecast to 2027 (US$ Million)
8.3.4 Academic and Research Institutions
8.3.4.1 Overview
8.3.4.2 Academic and Research Institutions: Adenosine Triphosphate (ATP) Swab Test Market- Revenue and Forecast to 2027 (US$ Million)
9. Adenosine Triphosphate (ATP) Swab Test Analysis and Forecasts To 2027 - Geographical Analysis
9.1 North America: Adenosine Triphosphate (ATP) Swab Test Market
9.1.1 Overview
9.1.2 North America: Adenosine Triphosphate (ATP) Swab Test Market, - Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.4 North America: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.5 North America: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2019 & 2027 (%)
9.1.6 US: Adenosine Triphosphate (ATP) Swab Test - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Adenosine Triphosphate (ATP) Swab Test - Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.6.3 US: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.7 Canada: Adenosine Triphosphate (ATP) Swab Test - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Adenosine Triphosphate (ATP) Swab Test - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
9.1.7.3 Canada: Adenosine Triphosphate (ATP) Swab Test Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.8 Mexico: Adenosine Triphosphate (ATP) Swab Test - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Adenosine Triphosphate (ATP) Swab Test - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.8.3 Mexico: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.2 Europe: Adenosine Triphosphate (ATP) Swab Test Market
9.2.1 Overview
9.2.2 Europe: Adenosine Triphosphate (ATP) Swab Test Market, - Revenue and Forecast to 2027 (USD Million)
9.2.3 Europe: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
9.2.4 Europe: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
9.2.5 Europe: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2019 & 2027 (%)
9.2.6 Germany: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.1 Germany: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.2 Germany: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
9.2.6.3 Germany: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
9.2.7 UK: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.2.7.1 UK: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.2.7.2 UK: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
9.2.7.3 UK: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
9.2.8 France: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.1 France: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.2 France: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
9.2.8.3 France: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
9.2.9 Spain: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.1 Spain: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.2 Spain: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
9.2.9.3 Spain: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
9.2.10 Italy: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.1 Italy: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.2 Italy: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
9.2.10.3 Italy: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
9.2.11 Rest of Europe: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.2.11.1 Rest of Europe: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.2.11.2 Rest of Europe: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
9.2.11.3 Rest of Europe: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
9.3 Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market
9.3.1 Overview
9.3.2 Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
9.3.4 Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
9.3.5 Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2019 & 2027 (%)
9.3.6 China: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.3.6.1 China: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.3.6.2 China: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
9.3.6.3 China: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
9.3.7 Japan: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.3.7.1 Japan: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.3.7.2 Japan: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
9.3.7.3 Japan: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
9.3.8 India: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.3.8.1 India: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.3.8.2 India: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
9.3.8.3 India: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
9.3.9 South Korea: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.3.9.1 South Korea: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.3.9.2 South Korea: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
9.3.9.3 South Korea: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
9.3.10 Australia: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.3.10.1 Australia: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.3.10.2 Australia: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
9.3.10.3 Australia: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
9.3.11 Rest of Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.3.11.1 Rest of Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.3.11.2 Rest of Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
9.3.11.3 Rest of Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
9.4 Middle East & Africa: Adenosine Triphosphate (ATP) Swab Test Market
9.4.1 Overview
9.4.2 Middle East & Africa: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (US$ Million)
9.4.3 Middle East & Africa Adenosine Triphosphate (ATP) Swab Test Market, by Products - Revenue and Forecast to 2027 (USD Million)
9.4.4 Middle East & Africa Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.4.5 Middle East & Africa Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2019 & 2027 (%)
9.4.6 Saudi Arabia: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.4.6.1 Saudi Arabia: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.4.6.2 Saudi Arabia Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.4.6.3 Saudi Arabia Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.4.7 UAE: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.4.7.1 UAE: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.4.7.2 UAE: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.4.7.3 UAE: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.4.8 South Africa: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.4.8.1 South Africa: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.4.8.2 South Africa Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.4.8.3 South Africa Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.4.9 Rest of Middle East and Africa: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.4.9.1 Rest of Middle East and Africa: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.4.9.2 Rest of Middle East & Africa Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.4.9.3 Rest of Middle East & Africa: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.5 South and Central America: Adenosine Triphosphate (ATP) Swab Test Market
9.5.1 Overview
9.5.2 South and Central America: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.5.3 South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.5.4 South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.5.5 South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2019 & 2027 (%)
9.5.6 Brazil: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Brazil: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.2 Brazil: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.5.6.3 Brazil: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.5.7 Argentina: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.1 Argentina: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.2 Argentina: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.5.7.3 Argentina: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.5.8 Rest of South and Central America: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.5.8.1 Rest of South and Central America: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
9.5.8.2 Rest of South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.5.8.3 Rest of South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
10. Impact Of COVID-19 Pandemic on Global Adenosine Triphosphate (ATP) Swab Test Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment Of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Adenosine Triphosphate (ATP) Swab Test Market -Industry Landscape
11.1 Overview
11.2 Recent Growth Strategies in The Adenosine Triphosphate (ATP) Swab Test Market
12. Company Profiles
12.1 3M
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Hygiena, LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Charm Sciences
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Kikkoman Biochemifa Co
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Neogen Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Ecolab
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Ruhof Healthcare Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 LuminUltra Technologies Ltd.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MERCK KGaA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Promicol
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 PCE Instruments
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Promega Corporation
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 CHARLES RIVER LABORATORIES, INC
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms, Adenosine Triphosphate (ATP) Swab Test Market
List of Tables
Table 1. North America: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 2. North America Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 3. US: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 4. US: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 5. Canada: Adenosine Triphosphate (ATP) Swab Test Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 6. Canada: Adenosine Triphosphate (ATP) Swab Test Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 7. Mexico: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 8. Mexico: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 9. Europe: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
Table 10. Europe: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 11. Germany: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
Table 12. Germany: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 13. UK: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
Table 14. UK: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 15. France: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
Table 16. France: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 17. Spain: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
Table 18. Spain: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 19. Italy: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
Table 20. Italy: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 21. Rest of Europe: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
Table 22. Rest of Europe: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 23. Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
Table 24. Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 25. China: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
Table 26. China: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 27. Japan: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
Table 28. Japan: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 29. India: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
Table 30. India: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 31. South Korea: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
Table 32. South Korea: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 33. Australia: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
Table 34. Australia: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 35. Rest of Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, By Application - Revenue and Forecast to 2027 (USD Million)
Table 36. Rest of Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 37. Middle East & Africa Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 38. Middle East & Africa Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 39. Saudi Arabia Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 40. Saudi Arabia Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 41. UAE: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 42. UAE: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 43. South Africa Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 44. South Africa Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million
Table 45. Rest of Middle East & Africa: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 46. Rest of Middle East & Africa: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 47. South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 48. South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 49. Brazil: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 50. Brazil: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 51. Argentina: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 52. Argentina: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 53. Rest of South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 54. Rest of South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 55. List of AbbreviationList of Figures
Figure 1. Adenosine Triphosphate (ATP) Swab Test Market Segmentation
Figure 2. Adenosine Triphosphate (ATP) Swab Test Market Segmentation, By Region
Figure 3. Global Adenosine Triphosphate (ATP) Swab Test Market Overview
Figure 4. Pharmaceutical and Biotechnology Company Segment Held Largest Share of Adenosine Triphosphate (ATP) Swab Test Market
Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period
Figure 6. Adenosine Triphosphate (ATP) Swab Test Market, by Geography (US$ Million)
Figure 7. Global Adenosine Triphosphate (ATP) Swab Test Market - Leading Country Markets (US$ Million)
Figure 8. Global Adenosine Triphosphate (ATP) Swab Test Market, Industry Landscape
Figure 9. North America : PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Adenosine Triphosphate (ATP) Swab Test Market Impact Analysis of Driver and Restraints
Figure 15. Global Adenosine Triphosphate (ATP) Swab Test Market - Revenue Forecast and Analysis - 2019- 2027
Figure 16. Global Adenosine Triphosphate (ATP) Swab Test Market - By Geography Forecast and Analysis - 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Adenosine Triphosphate (ATP) Swab Test Market
Figure 18. Global Adenosine Triphosphate (ATP) Swab Test Market Share by Type 2019 & 2027 (%)
Figure 19. Free ATP Test Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 20. Microbial ATP Test Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 21. Global Adenosine Triphosphate (ATP) Swab Test Market Share by Application 2019 & 2027 (%)
Figure 22. Pharmaceutical and biopharmaceutical companies Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 23. Food and Beverage: Adenosine Triphosphate (ATP) Swab Test Market- Revenue and Forecast to 2027 (US$ Million)
Figure 24. Hospitals and Diagnostics Laboratories: Adenosine Triphosphate (ATP) Swab Test Market- Revenue and Forecast to 2027 (US$ Million)
Figure 25. Academic and Research Institutions: Adenosine Triphosphate (ATP) Swab Test Market- Revenue and Forecast to 2027 (US$ Million)
Figure 26. North America: Adenosine Triphosphate (ATP) Swab Test Market, by Key Country - Revenue (2019) (USD Million)
Figure 27. North America: Adenosine Triphosphate (ATP) Swab Test Market, Revenue and Forecast to 2027 (USD Million)
Figure 28. North America: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2019 & 2027 (%)
Figure 29. US: Adenosine Triphosphate (ATP) Swab Test - Revenue and Forecast to 2027 (USD Million)
Figure 30. Canada: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 31. Mexico: Adenosine Triphosphate (ATP) Swab Test - Revenue and Forecast to 2027 (USD Million)
Figure 32. Europe: Adenosine Triphosphate (ATP) Swab Test Market, by Key Country - Revenue (2019) (USD Million)
Figure 33. Europe: Adenosine Triphosphate (ATP) Swab Test Market, Revenue and Forecast to 2027 (USD Million)
Figure 34. Europe: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2019 & 2027 (%)
Figure 35. Germany: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 36. UK: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 37. France: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 38. Spain: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 39. Italy: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 40. Rest of Europe: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 41. Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, by Key Country - Revenue (2019) (USD Million)
Figure 42. Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, Revenue and Forecast to 2027 (USD Million)
Figure 43. Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2019 & 2027 (%)
Figure 44. China: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 45. Japan: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 46. India: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 47. South Korea: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 48. Australia: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 49. Rest of Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 50. Middle East & Africa: Adenosine Triphosphate (ATP) Swab Test Market, by Key Country - Revenue (2019) (USD Million)
Figure 51. Middle East & Africa Adenosine Triphosphate (ATP) Swab Test Market Revenue and Forecast to 2027 (USD Million)
Figure 52. Middle East & Africa: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2019 & 2027 (%)
Figure 53. Saudi Arabia: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 54. UAE: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 55. South Africa: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 56. Rest of Middle East and Africa: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 57. South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Key Country - Revenue (2019) (USD Million)
Figure 58. South and Central America Adenosine Triphosphate (ATP) Swab Test Market Revenue and Forecast to 2027 (USD Million)
Figure 59. South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2019 & 2027 (%)
Figure 60. Brazil: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 61. Argentina: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 62. Rest of South and Central America: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2027 (USD Million)
Figure 63. Impact of COVID-19 Pandemic in North American Country Markets
Figure 64. Impact of COVID-19 Pandemic in European Country Markets
Figure 65. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 66. Impact Of COVID-19 Pandemic in Middle East and Africa Market
Figure 67. Impact of COVID-19 Pandemic in South and Central America Market
Companies Mentioned
- Hygiena, LLC
- 3M
- Charm Sciences, Inc.
- Kikkoman Biochemifa
- Neogen
- Ecolab
- Ruhof Healthcare Corporation
- Luminultra Technologies Ltd.
- Charles River Laboratories, Inc
- Promicol
- PCE Instruments
- Promega Corporation
- Merck KGaA
Table Information
| Report Attribute | Details |
|---|---|
| Published | January 2021 |
| Forecast Period | 2019 - 2027 |
| Estimated Market Value ( USD | $ 198.21 Million |
| Forecasted Market Value ( USD | $ 369.71 Million |
| Compound Annual Growth Rate | 8.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
